medigraphic.com
Instituto Nacional de Salud Pública

2025, Number 2

<< Back Next >>

salud publica mex 2025; 67 (2)

External evaluation of the mammography screening program in Mexico, 2017

Romo-Dueñas D, Ángeles-Llerenas A, Uscanga-Sánchez S, Méndez LJJ, Torres-Mejía G, Hurtado-Salgado E, Saavedra-Lara N, Lazcano-Ponce E

Language: Spanish
References: 27
Page: 135-143
PDF size: 459.51 Kb.


ABSTRACT

Objective. To analyze the program’s results for timely detection of breast cancer through screening by the Ministry of Health in Mexico (2017) using six process indicators and compare them with the 2011 measurement and the World Health Organization standards. Materials and methods. We assessed six process indicators of the program: 1) the target population for mammography screening; 2) the availability of screening infrastructure; 3) mammography coverage; 4) the proportion of cases receiving specialized evaluation; 5) the proportion of cases with suspicious findings requiring biopsy and confirmation of diagnosis; and 6) the proportion of cases initiating treatment. We compared these indicators with those from 2011 and with international standards. We also graphed the program indicators at the national level and based on the level of marginalization. Results. The coverage of the last five indicators was 38.1, 19.1, 13.3, 5.3, and 38.3%, respectively. Compared to the previous five indicators from 2011, those from 2017 showed an increase of 1.1, 4.1, 9.0, 3.2, and 37.1%, respectively. Conclusions. The results revealed that the breast cancer prevention and control program had performed inadequately; it was found that there was not enough capacity to screen all women aged 40 to 69 who are part of the Ministry of Health’s user base.


REFERENCES

  1. Muratov S, Canelo-Aybar C, Tarride JE, Alonso-Coello P, Dimitrova N,Borisch B, et al. Monitoring and evaluation of breast cancer screeningprogrammes: selecting candidate performance indicators. BMC Cancer. 2020;20(1):795. https://doi.org/10.1186/s12885-020-07289-z

  2. Naranjo M. Evaluación de programas de salud. Comunidad y Salud.2006;4(2):34-7 [citado julio 10, 2024]. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S1690-32932006000200005&nrm=iso

  3. Mills A. Health care systems in low- and middle-income countries. NEngl J Med. 2014;370(6):552-7. https://doi.org/10.1056/NEJMra1110897

  4. Uscanga-Sánchez S, Torres-Mejía G, Ángeles-Llerenas A, Domínguez-Malpica R, Lazcano-Ponce E. Breast cancer screening process indicatorsin Mexico: a case study. Salud Publica Mex. 2014;56(5):528-37 [citado julio10, 2024]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342014000500020&lng=es

  5. Torres-Mejía G, Ortega-Olvera C, Ángeles-Llerenas A, Villalobos-Hernández AL, Salmerón-Castro J, Lazcano-Ponce E, et al. Patrones deutilización de programas de prevención y diagnóstico temprano de cánceren la mujer. Salud Pública de México. 2013;55(supl 2):s241-8 [citado julio10, 2024]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342013000800022&lng=es

  6. McClellan SP, Unger-Saldaña K, Neuhaus JM, Potter MB, García-Peña C,Torres JM. Mammography prevalence in Mexico from 2001-2018: Resultsfrom the Mexican Health and Aging study. Prev Med Rep. 2023;32:102150.https://doi.org/10.1016/j.pmedr.2023.102150

  7. Hurtado-Salgado E, Ortiz-Panozo E, Salmerón J, Saavedra-Lara N, Kuri-Morales P, Pesqueira-Villegas E, et al. Use of HPV testing in cervical cancerscreening services in Mexico, 2008-2018: a nationwide database study.Salud Publica Mex. 2018;60(6):722-33. https://doi.org/10.21149/9891

  8. Secretaría de Salud. Cubos dinámicos. México: SS, 2016 [citado julio 10,2024]. Disponible en: http://www.dgis.salud.gob.mx/contenidos/acercade/atribuciones_gobmx.html

  9. Secretaría de Salud. Norma Oficial Mexicana NOM-041-SSA2-2011. México:DOF, 2011 [citado julio 10, 2024]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/equipoMedico/normas/NOM_041_SSA2_2011.pdf

  10. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectivenessof Breast Cancer Screening: Systematic Review and Meta-analysisto Update the 2009 U.S. Preventive Services Task Force Recommendation.Ann Intern Med. 2016;164(4):244-55. https://doi.org/10.7326/m15-0969

  11. Rodríguez-Eguizabal E, Gil-de Gómez MJ, San Sebastián M, Oliván-Blázquez B, Coronado-Vázquez V, Sánchez-Calavera MA, et al. Capacidadde respuesta del sistema de salud en atención primaria valorada porpacientes con enfermedades crónicas. Gaceta Sanitaria. 2022;36(3):232-9 [citado julio 10, 2024]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112022000300006&nrm=iso

  12. International Agency for Research on Cancer I. Effectiveness of breastcancer screening. Handbooks of Cancer Prevention: Breast CancerScreening. Lyon: IARC, 2016 [citado julio 10, 2024]. Disponible en: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Breast-Cancer-Screening-2016

  13. Consejo Nacional de Población. Índice de marginación a nivel entidad. México:Conapo, 2016 [citado julio 12, 2024]. Disponible en: http://www.conapo.gob.mx/es/CONAPO/Datos_Abiertos_del_Indice_de_Marginacion

  14. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood ratiosfor modern screening mammography. Risk of breast cancer based onage and mammographic interpretation. Jama. 1996;276(1):39-43. https://doi.org/10.1001/jama.276.1.39

  15. Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, KerlikowskeK, et al. National performance benchmarks for modern screeningdigital mammography: update from the Breast Cancer SurveillanceConsortium. Radiology. 2017;283(1):49-58. https://doi.org/10.1148/radiol.2016161174

  16. World Health Organization. Early Detection. Cancer ControlKnowledge into Action WHO Guide for Effective Programmes. WHO,2017 [citado diciembre 11, 2023]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/43743/9241547338_eng.pdf;jsessionid=0422FF2CCD0172DA6F61A1B5933483A7?sequence=1

  17. da Mota Almeida-Peroni F, Lindelow M, Oliveira De Souza D, SjoblomM. Realizing the right to health in Brazil’s Unified Health System throughthe lens of breast and cervical cancer. Int J Equity Health. 2019;18(1):39.https://doi.org/10.1186/s12939-019-0938-x

  18. Shamah Levy T, Rivera-Dommarco J, Bertozzi S. Encuesta Nacional deSalud y Nutrición 2018-19: análisis de sus principales resultados. SaludPública de México. 2020;62(6):614-7. https://doi.org/10.21149/12280

  19. Secretaría de Salud. Programa de Acción Cáncer SSA 2022 Secretaríade Salud. México: SEGOB, 2021 [citado diciembre 11, 2023]. Disponibleen: https://www.gob.mx/salud/censia/documentos/programas-de-accionespecifica-

  20. 2020-202420. Puschel K, Rioseco A, Soto G, Palominos M, León A, Soto M, et al.Long-term mammography utilization after an initial randomized interventionperiod by all underserved Chilean women in the clinics. Cancers(Basel). 2022;14(15)3734. https://doi.org/10.3390/cancers14153734

  21. Sollozo-Dupont I, Galván-Espinoza HA, Villaseñor Y. Availability ofmammographs in Mexico: Is it possible to expand coverage. Rev MedInst Mex Seguro Soc. 2023;61(6):736-46. https://doi.org/10.5281/zenodo.10064296

  22. Unger-Saldaña K. Challenges to the early diagnosis and treatment ofbreast cancer in developing countries. World J Clin Oncol. 2014;5(3):465-77. https://doi.org/10.5306/wjco.v5.i3.465

  23. Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, Dunstan-Yataco JA,et al. Breast cancer early detection: A phased approach to implementation.Cancer. 2020; 126(supl 10):2379-93. https://doi.org/10.1002/cncr.32887

  24. Haggerty J, Burge F, Lévesque JF, Gass D, Pineault R, Beaulieu MD, et al.Operational definitions of attributes of primary health care: consensusamong Canadian experts. Ann Fam Med. 2007;5(4):336-44. https://doi.org/10.1370/afm.682

  25. Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z,et al. Breast cancer treatment: A phased approach to implementation. Cancer.2020;126(supl 10):2365-78. https://doi.org/10.1002/cncr.32910

  26. World Health Organization. Assessing national capacity for the preventionand control of noncommunicable diseases: global survey. WHO, 2016[citado diciembre 11, 2023]. Disponible en: https://iris.who.int/bitstr%20eam/10665/246223/1/9789241565363-eng.pdf?ua=1

  27. Restrepo-Sierra LH, López-Ríos MM. Sistema de información para lacalidad en salud: una realidad por explorar, para conocer y decidir responsablemente.CES Salud Pública. 2015(1);6:52-62 [citado diciembre 11,2023]. Disponible en: http://revistas.ces.edu.co/index.php/ces_salud_publica/article/view/2979




2020     |     www.medigraphic.com